Janine Erler PhD

Janine Terra Erler is CEO of NEUmiRNA Therapeutics, a start-up based in Copenhagen, that is focusing on achieving transformative disease modification for neurological conditions through the development of RNA therapies. NEUmiRNA was founded in 2020 and since Janine Erler started as its CEO in 2022, she has secured €1.4 million worth of investments from Innovestor Life Science Fund (Q1 2023) and Sunstone Life Alliance (Q4 2022), two of the leading Nordic VC investment companies. Janine Erler has also secured €2 million in grant funding for the company. In addition, as a long-standing Professor at the University of Copenhagen, Janine Erler is a lead cancer researcher in the field of metastasis.

With more than 23 years of experience in academic research – including 16 years leading an independent research group – Janine Erler trained at Stanford University and INSEAD Business School. With a lifetime goal of reducing the suffering of as many patients as possible, Janine Erler founded two start-ups between 2018 and 2022, for which she acted as CEO. In 2017, Janine Erler also established a precision medicine program after securing funding from the Innovation Fund Denmark. As project leader, Janine ran this project for five years. Janine Erler's strengths are her people skills, strategic thinking, efficiency, determination, resilience, and positive energy.